Gastroenterology

Gastroenterology

Volume 112, Issue 6, June 1997, Pages 1839-1844
Gastroenterology

Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease

https://doi.org/10.1053/gast.1997.v112.pm9178674Get rights and content

Abstract

BACKGROUND & AIMS: Clinical significance and duration of insufficient release of pancreatic enzymes in childhood celiac disease have not been clarified. The aim of this study was to evaluate the role that pancreatic impairment plays in growth recovery and the duration of this impairment. METHODS: Forty-six patients with celiac disease who had a median age of 2.5 years were enrolled. Fecal chymotrypsin level was determined at diagnosis and then every 15 days after the beginning of a gluten-free diet in all patients. RESULTS: At diagnosis, 17 of 46 patients with celiac disease had subnormal fecal chymotrypsin values. During the gluten-free diet, a progressive reduction in the percentage of patients with subnormal fecal chymotrypsin values was observed: 12 of 46 patients after 30 days and 2 of 46 patients after 60 days. Weight increase after 2 months of gluten-free diet was significantly greater in patients with normal fecal chymotrypsin values at diagnosis than in patients with subnormal values, and a positive correlation was found between fecal chymotrypsin at diagnosis and weight increase (r = 0.56). CONCLUSIONS: A small percentage of patients with celiac disease still had subnormal chymotrypsin concentrations after 60 days of gluten-free diet. Fecal chymotrypsin is a predictive index of weight recovery in the first months after diagnosis of celiac disease; it could be used to select patients for enzyme supplementation therapy. (Gastroenterology 1997 Jun;112(6):1839-44)

References (0)

Cited by (53)

  • Nutritional considerations in the management of gluten-related disorders

    2017, Nutrition in the Prevention and Treatment of Disease
  • Nutritional Considerations in the Management of Celiac Disease

    2013, Nutrition in the Prevention and Treatment of Disease
  • Nutritional Considerations in the Management of Celiac Disease

    2012, Nutrition in the Prevention and Treatment of Disease, Third Edition
  • Selected Disorders of Malabsorption

    2011, Primary Care - Clinics in Office Practice
    Citation Excerpt :

    Histologically evident celiac disease should be adequately evaluated in such patients with multiple intestinal biopsies, however, because the histologic abnormalities can be patchy.60 Patients with refractory sprue fall into 2 clinical categories61: patients who have no initial response to a gluten-free diet and patients who experience initial clinical improvement on a gluten-free diet but after a period of remission develop disease refractory to gluten abstinence. Refractory sprue has also been subdivided into 2 immunologic categories62:

  • Tests of pancreatic exocrine function - Clinical significance in pancreatic and non-pancreatic disorders

    2009, Best Practice and Research: Clinical Gastroenterology
    Citation Excerpt :

    Indirect pancreatic function tests such as the 13C-mixed triglyceride breath test may help to confirm and to quantify nutrient maldigestion and malabsorption. In children with coeliac disease determination of fecal chymotrypsin seems to be a predictor for weight gain under gluten free diet (patients with low chymotrypsin display lower weight gain) [79] and may therefore help to guide therapy. Pancreatic disorders are considered to be an extraintestinal manifestation of inflammatory bowel disease (IBD) and patients have a markedly increased risk for developing acute pancreatitis.

View all citing articles on Scopus
View full text